Detailed View
PLSE - Pulse Biosciences, Inc
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
3,463,426,048
Adj EBIT (TTM)
-83,042,000
Enterprise Value
3,361,806,048
Last Price
48.56
Earnings Yield
-2.47%
Return on Capital
-81.76%
Capital
101,573,000
1Y Price Chart
Last Price: $48.56
1Y Change: 187.17%
As of 2026-08-27 | 1Y Change: 187.17%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 434,000 | -25,272,000 |
| 2026-03-31 | 10-Q | 2026 | 401,000 | -19,150,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 264,000 | -18,253,000 |
| 2025-09-30 | 10-Q | 2025 | 86,000 | -20,367,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -20,275,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -18,044,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -20,261,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -13,655,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.